Advertisement

Antimicrobials

  • Edward PurssellEmail author
Chapter
  • 35 Downloads

Abstract

This chapter introduces the reader to the treatment of infections with antimicrobial drugs. In doing so, an ecological and evolutionary approach is taken that sees humans as just one part of the biosphere, which is the totality of life on earth. Our interaction with microorganisms is constant and ever changing, and it is this dynamic relationship between evolving organisms that makes the treatment of infectious diseases so challenging.

Early in the chapter, this ecological approach is introduced, followed by the key to treating infectious diseases, which is the concept of selective toxicity. After that the key groups of organisms and their treatment are discussed, most notably bacteria, viruses and fungi, but also protozoa and helminths. More general topics of identification, testing and resistance are then discussed and before the chapter ends with consideration of opportunistic infections and pharmacological approaches to prevention.

Keywords

Antibiotics Antimicrobial resistance Antibacterial Antiviral Antifungal Antiprotozoan Antimicrobial Infection 

References

  1. Antonelli G, Turriziani O (2012) Antiviral therapy: old and current issues. Int J Antimicrob Agents 40:95–102.  https://doi.org/10.1016/j.ijantimicag.2012.04.005 CrossRefPubMedGoogle Scholar
  2. Appelbaum PC (2007) Reduced glycopeptide susceptibility in methicillin-resistant Staphylococcus aureus (MRSA). Int J Antimicrob Agents 30:398–408.  https://doi.org/10.1016/j.ijantimicag.2007.07.011 CrossRefPubMedGoogle Scholar
  3. Belkaid Y, Hand TW (2014) Role of the microbiota in immunity and inflammation. Cell 157:121–141.  https://doi.org/10.1016/j.cell.2014.03.011 CrossRefPubMedPubMedCentralGoogle Scholar
  4. Berger M (2018) Antibodies to vaccine antigens in pooled polyclonal human IgG products. Transfusion 58:3096–3105.  https://doi.org/10.1111/trf.15017 CrossRefPubMedGoogle Scholar
  5. British Society for Antimicrobial Chemotherapy 2018. Definitions | BSAC. http://www.bsacsurv.org/science/mics/. Accessed 24 Feb 2019
  6. Centres for Disease Control and Prevention (1981) Pneumocystis pneumonia—Los Angeles. MMWR 30:250–252Google Scholar
  7. Chabé M, Lokmer A, Ségurel L (2017) Gut protozoa: friends or foes of the human gut microbiota? Trends Parasitol 33:925–934.  https://doi.org/10.1016/j.pt.2017.08.005 CrossRefPubMedGoogle Scholar
  8. Cox G, Wright GD (2013) Intrinsic antibiotic resistance: mechanisms, origins, challenges and solutions. Int J Med Microbiol 303:287–292.  https://doi.org/10.1016/j.ijmm.2013.02.009 CrossRefPubMedGoogle Scholar
  9. Davies J, Davies D (2010) Origins and evolution of antibiotic resistance. Microbiol Mol Biol Rev 74:417–433.  https://doi.org/10.1128/MMBR.00016-10 CrossRefPubMedPubMedCentralGoogle Scholar
  10. Davies JM, Lewis MPN, Wimperis J, Rafi I, Ladhani S, Bolton-Maggs PHB, British Committee for Standards in Haematology (2011) Review of guidelines for the prevention and treatment of infection in patients with an absent or dysfunctional spleen: prepared on behalf of the British Committee for Standards in Haematology by a working party of the Haemato-oncology task force. Br J Haematol 155:308–317.  https://doi.org/10.1111/j.1365-2141.2011.08843.x CrossRefPubMedGoogle Scholar
  11. Foster TJ (2017) Antibiotic resistance in Staphylococcus aureus. Current status and future prospects. FEMS Microbiol Rev 41:430–449.  https://doi.org/10.1093/femsre/fux007 CrossRefPubMedGoogle Scholar
  12. Giedraitienė A, Vitkauskienė A, Naginienė R, Pavilonis A (2011) Antibiotic resistance mechanisms of clinically important bacteria. Medicina (Kaunas) 47:137–146Google Scholar
  13. Gillings MR, Stokes HW (2012) Are humans increasing bacterial evolvability? Trends Ecol. Evol (Amst) 27:346–352.  https://doi.org/10.1016/j.tree.2012.02.006 CrossRefGoogle Scholar
  14. Grencis RK (2015) Immunity to Helminths: resistance, regulation, and susceptibility to gastrointestinal nematodes. Annu Rev Immunol 33:201–225.  https://doi.org/10.1146/annurev-immunol-032713-120218 CrossRefPubMedGoogle Scholar
  15. Hughes D, Andersson DI (2017) Evolutionary trajectories to antibiotic resistance. Annu Rev Microbiol 71:579–596.  https://doi.org/10.1146/annurev-micro-090816-093813 CrossRefPubMedGoogle Scholar
  16. Kapoor G, Saigal S, Elongavan A (2017) Action and resistance mechanisms of antibiotics: a guide for clinicians. J Anaesthesiol Clin Pharmacol 33:300–305.  https://doi.org/10.4103/joacp.JOACP_349_15 CrossRefPubMedPubMedCentralGoogle Scholar
  17. Kathiravan MK, Salake AB, Chothe AS, Dudhe PB, Watode RP, Mukta MS, Gadhwe S (2012) The biology and chemistry of antifungal agents: a review. Bioorg Med Chem 20:5678–5698.  https://doi.org/10.1016/j.bmc.2012.04.045 CrossRefPubMedGoogle Scholar
  18. Laniado-Laborín R, Cabrales-Vargas MN (2009) Amphotericin B: side effects and toxicity. Rev Iberoam Micol 26:223–227.  https://doi.org/10.1016/j.riam.2009.06.003 CrossRefPubMedGoogle Scholar
  19. Leibovici L, Shraga I, Andreassen S (1999) How do you choose antibiotic treatment? BMJ 318:1614–1616CrossRefGoogle Scholar
  20. Leone S, Cascella M, Pezone I, Fiore M (2019) New antibiotics for the treatment of serious infections in intensive care unit patients. Curr Med Res Opin 35(8):1331–1334.  https://doi.org/10.1080/03007995.2019.1583025 CrossRefPubMedGoogle Scholar
  21. Littler E, Oberg B (2005) Achievements and challenges in antiviral drug discovery. Antivir Chem Chemother 16:155–168.  https://doi.org/10.1177/095632020501600302 CrossRefPubMedGoogle Scholar
  22. Mayon-White RT, Wiffen P (2005) Audit of antibiotic policies in the south east of England, 2004. J Antimicrob Chemother 56:204–207.  https://doi.org/10.1093/jac/dki152 CrossRefPubMedGoogle Scholar
  23. National Institute for Health and Care Excellence, (2015). Antimicrobial stewardship: systems and processes for effective antimicrobial medicine use [NG15] [WWW document]. URL. https://www.nice.org.uk/guidance/ng15. Accessed 24 Feb 2019
  24. National Institute for Health and Care Excellence, (2019). Surgical site infections: prevention and treatment, Clinical Guideline [NG125]. https://www.nice.org.uk/guidance/ng125/chapter/Recommendations#preoperative-phase
  25. Phillips MA, Burrows JN, Manyando C, van Huijsduijnen RH, Van Voorhis WC, Wells TNC (2017) Malaria. Nat Rev Dis Primers 3:17050CrossRefGoogle Scholar
  26. Rai J, Randhawa GK, Kaur M (2013) Recent advances in antibacterial drugs. Int J Appl Basic Med Res 3:3–10.  https://doi.org/10.4103/2229-516X.112229 CrossRefPubMedPubMedCentralGoogle Scholar
  27. Rodloff A, Bauer T, Ewig S, Kujath P, Müller E (2008) Susceptible, intermediate, and resistant - the intensity of antibiotic action. Dtsch Arztebl Int 105:657–662.  https://doi.org/10.3238/arztebl.2008.0657 CrossRefPubMedPubMedCentralGoogle Scholar
  28. Sandoval-Motta S, Aldana M (2016) Adaptive resistance to antibiotics in bacteria: a systems biology perspective: adaptive resistance to antibiotics in bacteria. Wiley Interdiscip Rev Syst Biol Med 8:253–267.  https://doi.org/10.1002/wsbm.1335 CrossRefPubMedGoogle Scholar
  29. Sultan I, Rahman S, Jan AT, Siddiqui MT, Mondal AH, Haq QMR (2018) Antibiotics, Resistome and resistance mechanisms: a bacterial perspective. Front Microbiol 9:2066.  https://doi.org/10.3389/fmicb.2018.02066 CrossRefPubMedPubMedCentralGoogle Scholar
  30. Tenover FC (2006) Mechanisms of antimicrobial resistance in bacteria. Am J Med 119:S3–S10.; discussion S62-70.  https://doi.org/10.1016/j.amjmed.2006.03.011 CrossRefPubMedGoogle Scholar
  31. Whitman WB, Coleman DC, Wiebe WJ (1998) Prokaryotes: the unseen majority. Proc Natl Acad Sci 95:6578–6583.  https://doi.org/10.1073/pnas.95.12.6578 CrossRefPubMedGoogle Scholar
  32. Woolhouse MEJ, Gowtage-Sequeria S (2005) Host range and emerging and reemerging pathogens. Emerging Infect Dis 11:1842–1847.  https://doi.org/10.3201/eid1112.050997 CrossRefPubMedPubMedCentralGoogle Scholar
  33. World Health Organization (2015) WHO | global action plan on antimicrobial resistance [WWW document]. WHO New York. http://www.who.int/antimicrobial-resistance/publications/global-action-plan/en/. Accessed 24 Feb 2019

Copyright information

© Springer Nature Switzerland AG 2020

Authors and Affiliations

  1. 1.School of Health Sciences, City, University of LondonLondonUK

Personalised recommendations